-
EP4263546
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4263546
| EP4263546 - DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 07.06.2024 Database last updated on 31.08.2024 | |
| Former | Request for examination was made Status updated on 22.09.2023 | ||
| Former | The international publication has been made Status updated on 25.06.2022 | ||
| Former | unknown Status updated on 24.12.2021 | Most recent event Tooltip | 12.06.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Chiesi Farmaceutici S.p.A. Via Palermo, 26/A 43122 Parma / IT | [2023/43] | Inventor(s) | 01 /
RANCATI, Fabio 43122 Parma / IT | 02 /
ACCETTA, Alessandro 43122 Parma / IT | 03 /
CAPELLI, Anna Maria 43122 Parma / IT | 04 /
PALA, Daniele 43122 Parma / IT | 05 /
EDWARDS, Christine 43122 Parma / IT | 06 /
PASQUA, Adele Elisa 43122 Parma / IT | 07 /
KAPADNIS, Prashant Bhimrao 43122 Parma / IT | 08 /
CHEGUILLAUME, Arnaud Jean Fran ois Auguste 43122 Parma / IT | [2023/43] | Representative(s) | Chiesi Farmaceutici S.p.A. Via Palermo, 26/A 43122 Parma / IT | [2023/43] | Application number, filing date | 21824399.6 | 13.12.2021 | [2023/43] | WO2021EP85378 | Priority number, date | EP20200214148 | 15.12.2020 Original published format: EP 20214148 | [2023/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022128851 | Date: | 23.06.2022 | Language: | EN | [2022/25] | Type: | A1 Application with search report | No.: | EP4263546 | Date: | 25.10.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.06.2022 takes the place of the publication of the European patent application. | [2023/43] | Search report(s) | International search report - published on: | EP | 23.06.2022 | Classification | IPC: | C07D491/048, A61K31/506, A61P11/00, A61P11/06 | [2023/43] | CPC: |
C07D491/048 (EP,KR,US);
A61K31/444 (KR);
A61K31/506 (KR);
A61K45/06 (US);
A61P11/00 (EP,KR);
A61P11/06 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/43] | Extension states | BA | 29.06.2023 | ME | 29.06.2023 | Validation states | MA | 29.06.2023 | MD | 29.06.2023 | TN | 29.06.2023 | Title | German: | DIHYDROFUROPYRIDINDERIVATE ALS RHO-KINASEHEMMER | [2023/43] | English: | DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS | [2023/43] | French: | DÉRIVÉS DE DIHYDROFUROPYRIDINE UTILISÉS COMME INHIBITEURS DE LA RHO KINASE | [2023/43] | Entry into regional phase | 29.06.2023 | National basic fee paid | 29.06.2023 | Designation fee(s) paid | 29.06.2023 | Examination fee paid | Examination procedure | 29.06.2023 | Examination requested [2023/43] | 29.06.2023 | Date on which the examining division has become responsible | 17.01.2024 | Amendment by applicant (claims and/or description) | 11.06.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 27.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO2004039796 (BAYER HEALTHCARE AG [DE], et al); | [AD]WO2019238628 (CHIESI FARM SPA [IT]); | by applicant | WO2004039796 | WO2006009889 | WO2009079008 | WO2010032875 | WO2012007539 | WO2014118133 | WO2018115383 | WO2018138293 | WO2019048479 | WO2019121223 | WO2019121233 | WO2019121406 | WO2019238628 | WO2020016129 |